초록 ▼

A vascular or endoluminal stent is adapted to be implanted in a vessel, duct or tract of a human body to maintain an open lumen at the site of the implant. The sidewall of the open-ended tubular structure of the stent is a base layer of a metal biologically compatible with blood and tissue of the hu

A vascular or endoluminal stent is adapted to be implanted in a vessel, duct or tract of a human body to maintain an open lumen at the site of the implant. The sidewall of the open-ended tubular structure of the stent is a base layer of a metal biologically compatible with blood and tissue of the human body. An intermediate metal particle layer of substantial greater radiopacity overlies the base layer, with particles bonded to the base layer and to each other to leave interstices therebetween as a repository for retaining and dispensing drugs or other agents for time release therefrom after the stent is implanted, to assist the stent in maintaining the lumen open. The particles are composed primarily of a noble metal—an alloy of platinum-iridium. The sidewall has holes extending therethrough, and the particle layer resides along the outward facing and inward facing surfaces, and the edges of the through holes and open ends of the sidewall. The larger particles are bonded to surfaces of the sidewall and progressively smaller particles are bonded to those and to each other up to the outer portion of the particle layer. Exposed surfaces of the particle layer are coated with ceramic-like iridium oxide or titanium nitrate, as a biocompatible material to inhibit irritation of tissue at the inner lining of the vessel when the stent is implanted. One or more anti-thrombotic, anti-platelet, anti-inflammatory and/or anti-proliferative drugs are retained in the interstices, together with a biodegradable carrier for time release therefrom. In an alternative embodiment, the intermediate layer is solid and the biodegradable carrier and drugs or agents therein are applied to the surface of the ceramic-like coating. Gene transfer is alternatively used to control tissue proliferation.

대표청구항 ▼

What is claimed is: 1. A method, comprising: providing a free-standing, expandable vascular metal stent including a first layer radially outward of at least one inner, metal-containing layer, the first layer comprising at least both: a) a ceramic material and b) a drug, contained within voids in sa

What is claimed is: 1. A method, comprising: providing a free-standing, expandable vascular metal stent including a first layer radially outward of at least one inner, metal-containing layer, the first layer comprising at least both: a) a ceramic material and b) a drug, contained within voids in said first layer, at least a substantial portion of said ceramic being positioned radially outward of said voids, wherein said ceramic material does not fully coat all outer surfaces of the first layer, and implanting the stent at the location of an angioplasty treatment. 2. The method of claim 1, wherein the ceramic material is selected from the group consisting of iridium oxide and titanium nitrate. 3. The method of claim 2, wherein the ceramic material is iridium oxide. 4. The method of claim 1, wherein the ceramic material has a thickness in the range from about 50 to 500 nanometers. 5. The method of claim 1, wherein the ceramic material does not block a release of the drug from the voids. 6. The method of claim 1, wherein the first layer has a thickness in the range from about to 4 to about 8 μm. 7. The method of claim 1, wherein the first layer comprises a noble metal. 8. The method of claim 7, wherein the first layer comprises an alloy of platinum and iridium. 9. The method of claim 1, wherein the at least one inner, metal-containing layer comprises a stainless steel or a nickel-titanium alloy. 10. The method of claim 1, wherein at least a substantial portion of the drug is positioned radially inward of the ceramic material. 11. A method, comprising: implanting a free-standing, expandable vascular metal stent at the location of an angioplasty treatment, the stent comprising: (a) a porous layer comprising voids; (b) a drug contained in the voids; and (c) a ceramic material on an outer surface of the porous layer, at least a substantial portion of the ceramic material being positioned radially outward of the voids, wherein the ceramic material does not fully coat all of the outer surface of the first layer. 12. The method of claim 11, wherein the porous layer comprises a noble metal; and wherein the ceramic material is selected from a group consisting of iridium oxide and titanium nitrate. 13. The method of claim 11, wherein the porous layer comprises an alloy of platinum and iridium. 14. The method of claim 11, wherein the porous layer has a thickness in the range from about 4 to about 8 μm; and wherein the ceramic material has a thickness in the range from about 50 to 500 nanometers. 15. The method of claim 11, wherein the ceramic material does not block a release of the drug from the voids. 16. The method of claim 11, further comprising a base metal layer, the porous layer being radially outward of the base metal layer. 17. The method of claim 16, wherein the base metal layer comprises a stainless steel or a nickel-titanium. 18. The method of claim 16, wherein the base metal layer has a thickness in the range from 60 to 80 μm. 19. The method of claim 11, wherein at least a substantial portion of the drug is positioned radially inward of the ceramic material. 20. A method, comprising: implanting a free-standing, expandable vascular metal stent at the location of an angioplasty treatment, the stent comprising: (a) a base metal layer, the base metal layer having a thickness in the range from 60 to 80 μm; (b) an intermediate porous layer being radially outward of the base metal layer, the intermediate porous layer having a thickness in the range from about 4 to about 8 μm, the intermediate porous layer comprising voids; (c) a drug contained in the voids; and (d) a ceramic material, at least a substantial portion of the ceramic material being positioned radially outward of the voids, wherein said ceramic material does not fully coat all outer surfaces of the intermediate porous layer. 21. The method of claim 20, wherein the base metal layer comprises a stainless steel or a nickel-titanium; wherein the intermediate porous layer comprises a noble metal; and wherein the ceramic material is selected from a group consisting of iridium oxide and titanium nitrate. 22. The method of claim 20, wherein the intermediate porous layer comprises an alloy of platinum and iridium. 23. The method of claim 20, wherein at least a substantial portion of the drug is positioned radially inward of the ceramic material.